TREM2 and Alzheimer disease: While our results provide a molecular mechanism for how the H157Y variant might alter risk of AD, they do not presently shed light on whether the pathogenic effect of the accelerated cleavage could arise from more rapid removal of TREM2 from the cell surface and/or from the increased abundance of the released NTF.